1 / 26

What Analgesics?

What Analgesics?. Paracetamol – Aspirin Nefopam NSAIDS Opioids Topical – capsaicin, rubifacients , nsaids , Local anaesthetics. Add on’s. Diazepam, methocarbamol. Amitriptylline TENS machine Stretching, massage, physio Osteopathy, Acupuncture Antidepressants. 3.

Télécharger la présentation

What Analgesics?

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. What Analgesics? • Paracetamol – • Aspirin • Nefopam • NSAIDS • Opioids • Topical – capsaicin, rubifacients, nsaids, Local anaesthetics

  2. Add on’s • Diazepam, methocarbamol. • Amitriptylline • TENS machine • Stretching, massage, physio Osteopathy, Acupuncture • Antidepressants

  3. 3 WHO's three step ladder to use of analgesic drugs www.who.int/cancer/palliative/painladder 2 1

  4. Opioids

  5. Opioids

  6. Equivalent strengths of transdermalopioids(i.e. Don’t mix up your fentanyl with your butrans!)

  7. S/e of opiates • constipation, nausea, somnolence, itching, dizziness, vomiting • Tolerance to SE usually occurs within few days, • Constipation & itching tend to persist • Manage with antiemetics (cyclizine), aperients (movicol), antihistamines • Respiratory depression only likely with major changes in dose, formulation or route. • Accidental overdose is most likely cause • Caution if >1 sedative drug or other disorders of respiratory control ( eg OSA)

  8. Long-term adverse effects • Endocrine impairment in both men and women • Hypothalamic-pituitary pituitary-adrenal/ gonadal axis suppression leading to amenorrhoea, infertility, reduced libido, infertility, depression, erectile dysfunction. • Immunological effects- in animals, effects on antimicrobialresponse and tumour surveillance. • Opioid induced hyperalgesia - reduce dose, change preparation • Pregnancy & neonatal effects

  9. Stopping strong opioid medication • Large differences between individuals in susceptibility to, and severity of, withdrawal syndrome • Symptoms last up to 72hrs following reduction/withdrawal. • Incremental dose reductions 10% -25% depending on patient response and bear in mind half life of preparation

  10. Recommendations 1: • Useful analgesia in the short and medium term. No data to support longer term use. • Useful in neuropathic pain too. • Complete relief of pain is rarely achieved. The goal should be to reduce pain sufficiently to facilitate engagement with rehabilitation and the restoration of useful function. Use as part of a wider management plan to reduce disability and improve QOL.

  11. Recommendations 2 • 80% of patients taking opioids experience at least one adverse effect. Discuss before treatment! DO NOT USE in pregnancy / children and use with caution in Elderly. • Resp. depression commoner if elderly/coprescription / comorbidity e.g. OSA. • Withdrawl symptoms – yawning, sweating abdo cramps common with abrupt withdrawl even short courses of tramadol.

  12. Recommendations 3 • Educate re long term effects of opioids, particularly in relation to endocrine and immune function. Warn re Steroid induced Hyperalgesia. • Do not use as first line • Consider carefully the decision to start long term therapy and make arrangements for long-term monitoring and follow-up. • Use modified release opioids for long term use

  13. Recommendations 4 • Avoid driving at the start of opioid therapy and following major dose changes. Patients responsibility to advise the DVLA that they are taking opioid medication. • Addiction is characterised by impaired control over use, craving and continued use despite harm.

More Related